Hepatitis C

New CDC Vital Signs Report: Few Diagnosed with Hepatitis C Receive Timely Treatment

A new CDC Vital signs report finds that too few people diagnosed with hepatitis C are being treated, despite the availability of drugs capable of curing this viral infection. According to CDC estimates: Overall, fewer than one in three people with health insurance receive direct-acting antiviral (DAA) treatment for hepatitis C within a year of …

New CDC Vital Signs Report: Few Diagnosed with Hepatitis C Receive Timely Treatment Read More »

Less than a third of adults with HCV receive timely treatment, says new CDC report

In the United States, few insured adults infected with the hepatitis C virus (HCV) are receiving timely treatment despite the availability of highly effective direct-acting antiviral (DAA) drugs, according to new data from a Centers for Disease Control and Prevention (CDC) Vital signs report. Findings showed that among HCV patients with continued insurance coverage, about …

Less than a third of adults with HCV receive timely treatment, says new CDC report Read More »